Poster

ANTI-TUMOR ACTIVITY IN NRG1+ PDAC

Author

Dr. Ernesto Wasserman

Condition

NRG1+ PDAC

Drug target

HER2/HER3

Drug moa

Blocking NRG1:HER3 binding and HER2:HER3 dimerization which results in suppression of tumor cell proliferation and survival

Source url

s3://convoke-optic-posters/2024-05-10/ESMO2023NRG1+PDAC.pdf

1 organization

1 product

Product

Organization